Stemcell Holdings, Inc. Share Price Other OTC
Equities
STMM
US85858N2027
Pharmaceuticals
Sales 2016 | 3.34M 264M | Sales 2017 | 6.18M 489M | Capitalization | 1.64M 130M |
---|---|---|---|---|---|
Net income 2016 | 1M 79.13M | Net income 2017 | 2M 158M | EV / Sales 2016 * | - |
Net cash position 2016 * | - 0 | Net cash position 2017 * | - 0 | EV / Sales 2017 * | - |
P/E ratio 2016 * |
-
| P/E ratio 2017 * |
-
| Employees | - |
Yield 2016 * |
-
| Yield 2017 * |
-
| Free-Float | 99% |
1st Jan change | Capi. | |
---|---|---|
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-11.43% | 33.3B | |
+75.79% | 27.92B | |
-13.58% | 15.85B | |
-3.89% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |